INV-155

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameINV-155
Drug Alias NameINV-150 seriesalpha lipoic acid derivative based therapeutics (InVasc Therapeutics)INV-155
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionLDL receptor modulators
TargetsLDL receptor
Therapy Area/IndicationsHypertensionStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInvasc Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInvasc Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsHypertensionStroke

Other Information

ATC CodeN/A
Related LinksN/A